Exchange: NASDAQ·Updated 09:49 AM EDT
CHRS logo

CHRS Coherus Oncology Inc.

$1.31
$0.04
(2.96%)
Today
EarningsNov 5
Mkt Cap$208.58M
Vol33,036.00

About CHRS

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
62

Bullish Sentiment

How do you feel about CHRS?

Advertisement|Remove ads.